8-K: Xylem Inc. Reports Strong Fourth-Quarter and Full-Year 2023 Results, Exceeding Expectations

Xylem Inc. announced impressive fourth-quarter and full-year 2023 financial results, with revenue and earnings surpassing previous guidance and strong organic growth.

Summary

• Xylem Inc. reported its fourth-quarter and full-year 2023 results, showcasing significant growth.
• Fourth-quarter orders increased by 42% to $2.0 billion on a reported basis and 10% organically.
• Revenue for the fourth quarter reached $2.1 billion, a 41% increase on a reported basis and 9% organically.
• Earnings per share for the fourth quarter were $1.10, up 34%, and $0.99 on an adjusted basis, down 1%.
• Full-year revenue was $7.4 billion, a 33% increase on a reported basis and 12% organically.
• Full-year earnings per share were $2.79, up 42%, and $3.78 on an adjusted basis, up 20%.
• The company has initiated 2024 full-year revenue guidance of $8.4 to $8.5 billion, with organic growth of 3% to 5%, and an adjusted earnings per share range of $4.00 to $4.20.
• Net income for the fourth quarter was $266 million, or $1.10 per share, with a net income margin of 12.6%.
• Adjusted net income for the fourth quarter was $239 million, or $0.99 per share.
• The fourth-quarter adjusted EBITDA margin was 19.6%, a year-over-year increase of 90 basis points.
• Xylem's Board of Directors declared a first-quarter dividend of $0.36 per share, a 9% increase, payable on March 20, 2024.

Sentiment

Score: 9

Explanation: The document conveys a very positive sentiment due to strong financial results, exceeding expectations, and positive future guidance. The integration of Evoqua is also progressing well, further boosting the positive outlook.

Positives

• Strong order growth of 42% in the fourth quarter indicates robust demand.
• The company's revenue, margin, and earnings per share all exceeded expectations.
• The integration of Evoqua is progressing faster than anticipated.
• Xylem is demonstrating strong operational performance and productivity savings.
• The company is experiencing strong price realization and higher volume.
• Xylem is forecasting a full-year 2024 free cash flow conversion to net income of approximately 115%.

Negatives

• Adjusted earnings per share for the fourth quarter decreased by 1% to $0.99.
• The results were partially offset by higher acquisition and integration costs related to the Evoqua transaction, purchase accounting intangible amortization, special charges, and restructuring and realignment costs.

Risks

• The company's future performance is subject to various risks, including economic conditions, geopolitical events, and supply chain disruptions.
• There are risks associated with the integration of Evoqua.
• The company faces potential challenges related to cybersecurity incidents and defects in products.
• Fluctuations in foreign currency exchange rates could impact financial results.
• The company is subject to legal, governmental, and regulatory claims and investigations.

Future Outlook

Xylem forecasts full-year 2024 revenue of approximately $8.4 to $8.5 billion, up approximately 14 to 15 percent on a reported basis and up approximately 3 to 5 percent on an organic basis. Full-year 2024 adjusted EBITDA margin is expected to be approximately 19.4 to 19.9 percent.

Management Comments

• Matthew Pine, Xylem president and CEO, stated that the team delivered an outstanding fourth quarter, fueling momentum as we enter 2024.
• Matthew Pine also noted that revenue, margin, and earnings per share all exceeded expectations, driven by strong execution on healthy demand across the business.
• Management expressed confidence in further growth and margin expansion in the year ahead due to resilient underlying demand and the integration of Evoqua.

Industry Context

This announcement highlights Xylem's strong position in the global water technology market, demonstrating its ability to capitalize on growing demand for water solutions. The acquisition of Evoqua further strengthens its market presence and expands its offerings.

Comparison to Industry Standards

• Xylem's organic revenue growth of 12% for the full year is strong compared to peers in the industrial sector, which have seen more modest growth.
• The adjusted EBITDA margin of 19.6% in Q4 is competitive with other large industrial companies, such as Danaher and Roper Technologies, which typically have margins in the 20-25% range.
• The company's focus on water technology aligns with global trends towards sustainability and resource management, positioning it well for future growth.
• The successful integration of Evoqua is a key differentiator, as many companies struggle with post-merger integration.

Stakeholder Impact

• Shareholders will benefit from the increased dividend and strong financial performance.
• Employees will be impacted by the ongoing integration of Evoqua and the company's growth initiatives.
• Customers will benefit from the expanded product and service offerings resulting from the Evoqua acquisition.
• Suppliers will be impacted by the company's increased scale and operational changes.
• Creditors will be impacted by the company's strong cash flow and financial position.

Next Steps

• Xylem will continue to focus on integrating Evoqua and leveraging its combined offerings.
• The company will execute its 2024 plan, focusing on growth and margin expansion.
• Xylem will continue to monitor and manage risks related to economic conditions, geopolitical events, and supply chain disruptions.

Key Dates

Keywords

water technology, financial results, revenue, earnings per share, EBITDA, organic growth, Evoqua, dividend, water infrastructure, adjusted earnings